Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Clasificación en acciones #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Precio por acción
$115.67
Capitalización bursátil
$285.98B
Cambio (1 día)
1.30%
Cambio (1 año)
25.31%
País
US
Comercio Merck & Co., Inc. (MRK)

Categoría

Ingresos de Merck & Co., Inc. (MRK)
Ingresos en Dec 2025 TTM: $65.01B
Según los últimos informes financieros de Merck & Co., Inc., los ingresos actuales de la empresa (TTM) son $65.01B. En 2024, la empresa obtuvo unos ingresos de $64.17B un aumento con respecto a los ingresos del año 2023, que fueron de $60.12B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Merck & Co., Inc. desde 2000 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $65.01B 0.00%
2025 $65.01B 1.31%
2024 $64.17B 6.74%
2023 $60.12B 1.40%
2022 $59.28B 21.72%
2021 $48.70B 17.31%
2020 $41.52B 6.13%
2019 $39.12B -7.50%
2018 $42.29B 5.41%
2017 $40.12B 0.79%
2016 $39.81B 0.78%
2015 $39.50B -6.48%
2014 $42.24B -4.08%
2013 $44.03B -6.84%
2012 $47.27B -1.62%
2011 $48.05B 4.48%
2010 $45.99B 67.66%
2009 $27.43B 15.00%
2008 $23.85B -1.44%
2007 $24.20B 6.90%
2006 $22.64B 2.84%
2005 $22.01B -4.18%
2004 $22.97B 2.17%
2003 $22.49B 4.85%
2002 $21.45B 1.16%
2001 $21.20B -47.48%
2000 $40.36B 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$65.18B 0.26%
US
$58.74B -9.65%
GB
$94.19B 44.89%
US
$61.16B -5.92%
US
$56.15B -13.63%
CH